149 related articles for article (PubMed ID: 16777499)
1. Atorvastatin associated liver disease.
Clarke AT; Mills PR
Dig Liver Dis; 2006 Oct; 38(10):772-7. PubMed ID: 16777499
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
Björnsson E; Jacobsen EI; Kalaitzakis E
J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
[TBL] [Abstract][Full Text] [Related]
3. Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report.
Rahier JF; Rahier J; Leclercq I; Geubel AP
Acta Gastroenterol Belg; 2008; 71(3):318-20. PubMed ID: 19198578
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Newman C; Tsai J; Szarek M; Luo D; Gibson E
Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
[TBL] [Abstract][Full Text] [Related]
5. Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies.
Minha S; Golzman G; Adar I; Rapoport M
Isr Med Assoc J; 2009 Jul; 11(7):440-1. PubMed ID: 19911499
[No Abstract] [Full Text] [Related]
6. Acute hepatic injury with atorvastatin: an unusual occurrence.
Vishwakarma P; Nehra R; Kumar A
Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
[TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis with concurrent atorvastatin and diltiazem.
Lewin JJ; Nappi JM; Taylor MH
Ann Pharmacother; 2002 Oct; 36(10):1546-9. PubMed ID: 12243603
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for rhabdomyolysis with simvastatin and atorvastatin.
Ronaldson KJ; O'Shea JM; Boyd IW
Drug Saf; 2006; 29(11):1061-7. PubMed ID: 17061911
[TBL] [Abstract][Full Text] [Related]
9. [Acute cholestatic hepatitis after atorvastatin reintroduction].
de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis revealed by atorvastatin.
Pelli N; Setti M; Ceppa P; Toncini C; Indiveri F
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):921-4. PubMed ID: 12867804
[TBL] [Abstract][Full Text] [Related]
11. Severe hepatic injury associated with different statins in patients with chronic liver disease: a nationwide population-based cohort study.
Chang CH; Chang YC; Lee YC; Liu YC; Chuang LM; Lin JW
J Gastroenterol Hepatol; 2015 Jan; 30(1):155-62. PubMed ID: 25041076
[TBL] [Abstract][Full Text] [Related]
12. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced liver injury associated with statins.
Russo MW; Scobey M; Bonkovsky HL
Semin Liver Dis; 2009 Nov; 29(4):412-22. PubMed ID: 19826975
[TBL] [Abstract][Full Text] [Related]
14. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
15. Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.
Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2004 Jun; 93(11):1417-8, A9. PubMed ID: 15165929
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin-induced diaphragmatic muscle impairment.
Sulem P; Bagheri H; Faixo Y; Montastruc JL
Ann Pharmacother; 2001 Oct; 35(10):1292-3. PubMed ID: 11675865
[No Abstract] [Full Text] [Related]
17. [Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy].
Hydzik P; Szpak D
Przegl Lek; 2011; 68(8):495-8. PubMed ID: 22010448
[TBL] [Abstract][Full Text] [Related]
18. Cholestatic liver dysfunction.
Wierzbicki AS; Crook MA
Lancet; 1999 Sep; 354(9182):954. PubMed ID: 10489985
[No Abstract] [Full Text] [Related]
19. Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.
Abourjaily HM; Alsheikh-Ali AA; Karas RH
Am J Cardiol; 2003 Apr; 91(8):999-1002, A7. PubMed ID: 12686348
[No Abstract] [Full Text] [Related]
20. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.
Hsyu PH; Schultz-Smith MD; Lillibridge JH; Lewis RH; Kerr BM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3445-50. PubMed ID: 11709322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
